Chinese General Practice ›› 2022, Vol. 25 ›› Issue (12): 1411-1417.DOI: 10.12114/j.issn.1007-9572.2021.02.117
Special Issue: 内分泌代谢性疾病最新文章合集; 中医最新文章合集; 泌尿系统疾病最新文章合集; 述评栏目最新文章合集
• Editorial • Next Articles
Received:
2021-11-05
Revised:
2021-11-25
Published:
2021-12-09
Online:
2022-03-21
Contact:
Yaoxian WANG
About author:
通讯作者:
王耀献
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2021.02.117
[1] |
IDF Diabetes Atlas,9th ed. Brussels,Belgium:2019[EB/OL]. [2021-09-20].
|
[2] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志,2021,13(4):315-409. DOI:10.3760/cma.j.cn115791-20210221-00095.
|
[3] |
American Diabetes Association. Microvascular complications and foot care:standards of medical care in diabetes—2021[J]. Diabetes Care,2021,44(suppl 1):s151-167. DOI:10.2337/dc21-s011.
|
[4] |
糖尿病肾病多学科诊治与管理共识专家组. 糖尿病肾病多学科诊治与管理专家共识[J]. 中国临床医生杂志,2020,48(5):522-527. DOI:10.3969/j.issn.2095-8552.2020.05.006.
|
[5] |
Kidney Disease Improving Global Outcomes(KDIGO) Diabetes Work Group. KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease[J]. Kidney Int,2020,98(4S):S1-115. DOI:10.1016/j.kint.2020.06.019.
|
[6] |
The US Renal Data System (USRDS)[EB/OL].[2021-09-20].
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
中华医学会糖尿病学分会微血管并发症学组.中国糖尿病肾脏病防治指南(2021年版)[J]. 中华糖尿病杂志,2021,13(8):762-784.
|
[12] |
中华医学会肾脏病学分会专家组. 糖尿病肾脏疾病临床诊疗中国指南[J]. 中华肾脏病杂志,2021,37(3):255-304.
|
[13] |
American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment:standards of medical care in diabetes—2021[J]. Diabetes Care,2021,44(Suppl 1):S111-124. DOI:10.2337/dc21-S009.
|
[14] |
|
[15] |
|
[16] |
|
[17] |
中国医师协会内分泌代谢科医师分会. 2型糖尿病合并慢性肾脏病患者口服降糖药治疗中国专家共识(2019年更新版)[J]. 中华内分泌代谢杂志,2019,6(35):447-452.
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
赵进喜,邓德强,李靖. 糖尿病肾病相关中医病名考辨[J]. 南京中医药大学学报,2005,21(5):288-289.
|
[35] |
|
[36] |
王楠,刘阳. 中药通过足细胞保护作用治疗糖尿病肾病Meta分析[J]. 实用中医内科杂志,2020,34(6):94-99. DOI:10.13729/j.issn.1671-7813.Z20191133.
|
[37] |
王凤,马燕云,贾运滨,等. 基于中医药治疗的糖尿病肾病与氧化应激相关性的Meta分析[J]. 中国中西医结合肾病杂志,2019,20(7):596-601.
|
[38] |
陆黎黎. 中医药治疗临床期糖尿病肾病的meta分析[D]. 北京:北京中医药大学,2019.
|
[39] |
杨霓芝,刘旭生. 糖尿病肾病诊断、辨证分型及疗效评定标准(试行方案)[J]. 上海中医药杂志,2007,41(7):7-8. DOI:10.16305/j.1007-1334.2007.07.003.
|
[40] |
高彦彬,刘铜华,李平. 糖尿病肾病中医防治指南[J]. 中国中医药现代远程教育,2011,9(4):151-153.
|
[41] |
北京中医药大学东直门医院. 消渴病肾病(糖尿病肾病)中医诊疗方案(2017年版)[J]. 中国实用乡村医生杂志,2017,24(8):66-68.
|
[42] |
刘倩,尹智炜,段姝伟,等. 糖尿病肾病中医辨证指南发展及应用[J]. 中华肾病研究电子杂志,2018,7(2):91-93.
|
[43] |
张婧,王奕祺,王耀光. 师承薛伯寿教授经验以三焦辨证指导糖尿病肾病治疗体会[J]. 天津中医药,2020,37(4):398-401.
|
[44] |
王新苗,杨浩宇,顾成娟,等. 黄芪、水蛭粉、大黄治疗糖尿病肾病经验——仝小林三味小方撷萃[J]. 吉林中医药,2020,40(1):5-7. DOI:10.13463/j.cnki.jlzyy.2020.01.002.
|
[45] |
中日友好医院临床医学研究所. 中医药治疗糖尿病肾病临床与基础研究——中日友好医院临床医学研究所李平教授团队学术研究进展[J]. 世界科学技术-中医药现代化,2017,19(4):530-541.
|
[46] |
|
[47] |
苗永辉,赵宗江,张新雪,等. 糖尿病肾病"肾痿"学说的建立与阐释[J]. 世界科学技术-中医药现代化,2017,19(6):1031-1037.
|
[48] | |
[49] |
肖永华. 吕仁和教授治疗糖尿病学术思想及其传承方法的研究[D]. 北京:北京中医药大学,2007:17-19.
|
[50] |
王耀献. 辨机论治慢性肾脏病[J]. 中国中西医结合肾病杂志,2016,17(10):847-849.
|
[51] |
王珍,王梦迪,刘笑慈,等. 王耀献教授从热邪论治糖尿病肾病经验[J]. 中国中西医结合肾病杂志,2014,15(5):379-380.
|
[52] |
王晓娜,王耀献,闫润泽,等. 清热消癥法治疗中期糖尿病肾病临床疗效观察[J]. 中华中医药杂志,2020,35(11):5873-5876.
|
[53] |
高亚斌,王耀献,郭敬,等. "以热为本,以期为纲"论治晚期糖尿病肾病[J]. 中华中医药杂志,2020,35(2):714-716.
|
[54] |
|
[55] |
|
[56] |
|
[57] |
|
[58] |
|
[59] |
|
[60] |
|
[61] |
代晓颖,张燕,易静,等. 中医药降低早期糖尿病肾病患者蛋白尿水平疗效的Meta分析[J]. 北京中医药大学学报,2016,39(2):144-150.
|
[62] |
范婷,杨晓晖,李怡,等. 益气补肾方治疗早期糖尿病肾病的系统评价与Meta分析[J]. 世界中西医结合杂志,2020,15(1):41-47. DOI:10.13935/j.cnki.sjzx.200108.
|
[63] |
吕沈辉. 益气养阴补肾活血法治疗糖尿病肾病Ⅲ期的Meta分析[D]. 武汉:湖北中医药大学,2020.
|
[64] |
殷芳. 早期糖尿病肾病相关因素研究与中药疗效评价[D]. 沈阳:辽宁中医药大学,2017.
|
[65] |
赵秋霜. 益气养阴活血法治疗糖尿病肾病的Meta分析[D]. 沈阳:辽宁中医药大学,2016.
|
[66] |
王新苗. 益气活血中药治疗糖尿病肾病的Meta分析及肾浊方作用机制探讨[D]. 北京:中国中医科学院,2020.
|
[67] |
陈欢. 益气养阴通络法治疗早期糖尿病肾病的meta分析[D]. 沈阳:辽宁中医药大学,2020.
|
[68] |
王倩,何涛,周佳丽,等. Meta分析关联网络药理学的补肾活血汤治疗糖尿病肾病的临床评价及其潜在作用机制探析[J]. 中草药,2021,52(6):1692-1705.
|
[69] |
苏嘉楠,石岩,杨宇峰. 加味真武汤治疗糖尿病肾病Meta分析[J]. 辽宁中医药大学学报,2018,20(11):73-79. DOI:10.13194/j.issn.1673-842x.2018.11.020.
|
[70] |
万亚琴,王小琴. 当归补血汤加减联合ACEI/ARB类药物治疗Ⅲ期和Ⅳ期糖尿病肾病的Meta分析[J]. 广东药科大学学报,2021,37(2):78-84. DOI:10.16809/j.cnki.2096-3653.2020122906.
|
[71] |
胡佳卉. 基于循证医学的中医药治疗糖尿病肾病临床证据分析研究[D]. 北京:北京中医药大学,2014.
|
[72] |
张李博,孙路,吴金鸿,等. 猪苓汤联合ACEI/ARB治疗糖尿病肾病Meta分析[J]. 亚太传统医药,2021,17(6):128-133.
|
[73] |
高雪. 基于IRS-1 Ser/Tyr磷酸化失衡探讨芪地糖肾颗粒治疗糖尿病肾病蛋白尿的机制[D]. 北京:北京中医药大学,2018.
|
[74] |
胡卫维,郑文江,严倩,等. 黄芪注射液联合西药治疗糖尿病肾病的系统评价/Meta分析的文献质量评价[J]. 世界科学技术-中医药现代化,2020,22(9):3254-3262.
|
[75] |
綦向军,莫嘉浩,周润吉,等. 红花注射液治疗糖尿病肾病的meta分析及试验序贯分析[J]. 中国现代应用药学,2020,37(15):1877-1883. DOI:10.13748/j.cnki.issn1007-7693.2020.15.014.
|
[76] |
王芳,徐涛. 肾康注射液治疗糖尿病肾病有效性和安全性的Meta分析[J]. 光明中医,2020,35(17):2639-2643.
|
[77] |
姚转娥,王鹏波,刘爱,等. 丹参川芎嗪注射液联合前列地尔治疗糖尿病肾病的Meta分析[J]. 中医药临床杂志,2020,32(6):1082-1087. DOI:10.16448/j.cjtcm.2020.0625.
|
[78] |
|
[79] |
吴晓芸,董必成,刘丽婷,等. 中药穴位贴敷佐治糖尿病肾病Ⅲ-Ⅳ期的Meta分析[J]. 中医药通报,2020,19(6):59-63. DOI:10.14046/j.cnki.zyytb2002.2020.06.018.
|
[80] |
陈美玲,孙鲁英,孙卫卫,等. 中药灌肠治疗Ⅳ期糖尿病肾病系统评价[J]. 中医学报,2020,35(12):2706-2712. DOI:10.16368/j.issn.1674-8999.2020.12.596.
|
[81] |
王安娜,郜贺,杨宇峰,等. 针刺治疗糖尿病肾病的荟萃分析[J]. 中医药导报,2019,25(9):81-86. DOI:10.13862/j.cnki.cn43-1446/r.2019.09.024.
|
[82] |
刘昉. 基于循证证据中成药治疗糖尿病合并慢性肾脏病临床应用指南研究[D]. 天津:天津中医药大学,2020.
|
[1] | ZHAO Lizhen, LI Weimin, JIANG Ruixia. Clinical Value of Systemic Immune-inflammation Index in the Diagnosis of Diabetic Kidney Disease in Community-dwelling Elderly Patients with Type 2 Diabetes [J]. Chinese General Practice, 2023, 26(18): 2227-2231. |
[2] | SHU Tao, GUO Zheng, WANG Fei, CHEN Shuyan. Analysis of the Correlation between Time in Range and Diabetic Kidney Disease [J]. Chinese General Practice, 2023, 26(15): 1873-1879. |
[3] | YAN Peng, SONG Jianling, FANG Xiangdong. Recent Developments in Parathyroid Hormone Type 1 Receptor and Kidney Disease [J]. Chinese General Practice, 2023, 26(11): 1398-1403. |
[4] | SHEN Fei, JIANG Weiping, MEI Xiaobin, HAN Yiping, ZHAO Jiayi, FAN Jian, GU Juan, SHEN Yanhong, XU Hongmei, ZHANG Dan, MEN Ying, DING Haiguang, CHEN Caiping, HAN Junhua. Influence of Microbiota-modulating Agents on Gut Flora in Community Patients with Diabetic Nephropathy [J]. Chinese General Practice, 2023, 26(09): 1112-1117. |
[5] | Yujie WANG, Jian WANG, Jingwei ZHOU. Effect of Qingre Xiaozheng Formula on Improving Renal Injury in a Rat Model of Diabetic Kidney Disease [J]. Chinese General Practice, 2022, 25(29): 3678-3685. |
[6] | Hanwen YANG, Yaoxian WANG, Qiaoru WU, Jiale ZHANG, Runze YAN, Xiaona WANG, Zhen WANG, Weiwei SUN. Efficacy and Safety of Xiezhuoxiaozheng Therapy in Diabetic Kidney Disease: a Clinical Study [J]. Chinese General Practice, 2022, 25(26): 3252-3257. |
[7] | Qishun WU, Jianqiang HE, Taina WANG, Yan XIA, Shu YU, Lin WANG. Analysis of New Cases of Hemodialysis in a Single Center in Recent Five Years [J]. Chinese General Practice, 2022, 25(21): 2582-2588. |
[8] |
YANG Guang, XU Xin, ZHANG Yu, XU Juan, JIANG Shujuan, XIA Li, ZHANG Yang, WANG Yikun, LI Zhongsheng, ZHANG Shiqi.
Relationships of Skin AGEs and Serum CN-1 with Microvascular Complications in Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2022, 25(09): 1082-1087. |
[9] | FANG Fengzhen,LI Zhuangmiao,CHEN Tingyu. Risk Factors for Type 2 Diabetic Kidney Disease:a Systematic Review [J]. Chinese General Practice, 2021, 24(33): 4261-4267. |
[10] | CHENG Liying,WANG Mengxi,ZHANG Zhu,SHAO Fengmin. Clinical Efficacy of Dangguibuxue Decoction as an Adjuvant Therapy for Diabetic Nephropathy:a Meta-analysis [J]. Chinese General Practice, 2021, 24(27): 3477-3483. |
[11] | WU Yu,ZHANG Zheng,FANG Jinying,WANG Yuedan,LI Wenge. Effectiveness and Safety of Immunosuppressive Agents Derived from Chinese Medicine with ACEI/ARB in Early- and Middle-stage Diabetic Nephropathy:a Meta-analysis [J]. Chinese General Practice, 2021, 24(24): 3101-3109. |
[12] | PANG Xinxin,SHI Xiujie,ZHANG Yage,PENG Zining,XING Yufeng,HAN Jiarui. Effect of Tongluo Digui Decoction on Non-dipper Blood Pressure,Urinary Sodium Excretion,and Renin-angiotensin-aldosterone System in Patients with Stage Ⅳ Diabetic Kidney Disease [J]. Chinese General Practice, 2021, 24(15): 1943-1950. |
[13] | ZHENG Shuping,YUAN Hong. Analysis of Risk Factors Related to Type 2 Diabetic Kidney Disease based on Physical Examination [J]. Chinese General Practice, 2020, 23(6): 707-711. |
[14] | PANG Xinxin,SHI Xiujie,ZHANG Yage,PENG Zining,XING Yufeng,HAN Jiarui. Clinical Effect of Tongluo Digui Decoction in Patients with Stage 4 Type 2 Diabetic Kidney Disease [J]. Chinese General Practice, 2020, 23(30): 3846-3850. |
[15] | ZHONG Yuling,FAN Haozhi,ZHANG Ru,WANG Hongliang,ZHANG Wei,TIAN Ting,WANG Qingqing,ZHANG Liuxin,WANG Jie. Associations between HbA1c Glycation Index and Risk of Chronic Complications of Diabetes Mellitus [J]. Chinese General Practice, 2020, 23(3): 276-280. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||